FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
PO:26:088 | Rheumatologic immune-related adverse events from immune checkpoint inhibitors: a monocentric retrospective study Giulio Fraticelli1|2, Nicola Farina1|2, Alessandro Tomelleri1|2, Marco Matucci Cerinic1|2, Corrado Campochiaro1|2, Lorenzo Dagna1|2. | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; 2Inflammation, Fibrosis and Ageing Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy.
175 -
PO:05:071 | Impact of age at onset on Spondyloarthritis clinical profile and quality of life: a monocentric cohort analysis Federico Fattorini1, Marco Di Battista1, Lorenzo Esti1, Cosimo Cigolini2, Andrea Delle Sedie2, Marta Mosca1|2, Linda Carli1 | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2Rheumatology Unit, AOUP, Pisa, Italy
51 -
PO:24:066 | Antibody profile in myositis and early risk of interstitial lung disease: clinical and laboratory correlations in patients with suspected rheumatologic disease Lindsay Brooke Boling1, Gaia Deleonardi2, Alarico Ariani3, Tania Silvestri2, Ana Gabriela Grondona2, Marica Trevisani3, Rita Mulè3, Enrica Vandelli3, Gentiana Vukatana3, Elisa Rossi3, Olga Addimanda3, Francesca Bergossi3, Angela Buffa3, Giovanni B. Canestrari3, Francesco Cianci3, Daniela Chiarini3, Laura Gigante3, Nicolò Girolimetto3, Daniele Lini3, Luca Magnani3, Mirco Magnani3, Erika Meleddu3, Francesca Pignataro3, Sofia Testoni3, Massimo Reta3 | 1Scuola di Allergologia ed Immunologia Clinica-Università di Bologna; 2LUM Laboratorio Unico Metropolitano - Immunologia Clinica, Ospedale Maggiore, Bologna; 3UO Medicina Interna ad indirizzo reumatologico SC interaziendale - IRCCS AOU, AUSL Bologna, Italy
212 -
PO:07:108 | Achievement of Treatment Targets and Maintenance of Response with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in a Real-world Setting: Final 2-year Outcomes from the UPHOLD Study Enrico Marchetta1, Andrew Östör2|8, Eugen Feist3, Prodromos Sidiropoulos4, Jérôme Avouac5, Martin Rebella6|7, Rajaie Namas9, Erin Mcdearmon Blondell10, Ivan Lagunes10, Tianming Gao10, Tim Shaw10, Suzan Attar11 | 1AbbVie Srl Roma, Italy; 2Monash University and Emeritus Research, Melbourne, Victoria, Melbourne, Australia; 3Helios Department of Rheumatology and Clinical Immunology, Vogelsang-Gommern, Vogelsang Gommern, Germany; 4Faculty of Medicine, University of Crete, Heraklion, Heraklion, Greece; 5Service de Rhumatologie, Hôpital Cochin, AP HP Centre Université Paris Cité, Parigi, France; 6Departamento de Medicina, Facultad de Medicina, Universidad de la República, Montevideo, Montevideo, Uruguay; 7Unidad de Enfermedades Autoinmunes Sistémicas, MUCAM, Montevideo, Montevideo, Uruguay; 8Australian National University, Camberra, Australia; 9Medical Subspecialties Institute, Division of Rheumatology, Cleveland Clinic Abu Dhabi, United Arab Emirates; 10AbbVie Inc., North Chicago, Illinois, United States of America Chicago, USA; 11King Abdulaziz University, Jeddah, Saudi Arabia
41 -
PO:36:246 | Early real-world outcomes with benralizumab in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective Richard Borrelli1, Stefania Nicola1, Federica Corradi1, Iuliana Badiu1, Marzia Boem1, Valentina Marmora1, Simone Negrini1, Luisa Brussino1. | 1SCDU Immunologia e Allergologia, AO Mauriziano, Dipartimento di Scienze Mediche, Università degli Studi di Torino, Torino, Italy.
164 -
PO:26:092 | Early antiproteinuric effect of voclosporine in patients with lupus nephritis in real life setting: preliminary results from the VoRLiSS (Voclosporine in Real Life Setting Study) Aurora Di Gregorio1, Marta Calatroni2, Marco Allinovi3, Alessandra Bortoluzzi4, Giorgio Buscetta5, Rossella De Angelis6, Ginevra De Marchi7, Giacomo Emmi8, Pasquale Esposito9, Paride Fenaroli10, Micaela Fredi11, Giovanni Orsolini12, Giulia Pazzola13, Domenico Santoro14, Andrea Doria1, Gabriella Moroni2, Luca Iaccarino1 | 1Azienda Ospedaliera Universitaria Padova, Italy; 2Ospedale IRCCS Humanitas Milano, Italy; 3Azienda Ospedaliero Universitaria Careggi Firenze, Italy; 4Azienda Ospedaliero Universitaria di Ferrara, Italy; 5Policlinico Universitario Paolo Giaccone Palermo, Italy; 6Università Politecnica delle Marche Ancona, Italy; 7Università di Udine, Italy; 8Università di Trieste, Italy; 9Università di Genova, Italy; 10Unità di Nefrologia AUSL IRCCS di Reggio Emilia, Italy; 11Università di Brescia, Italy; 12Università di Verona Verona, Italy; 13Università di Reggio Emilia, Italy; 14Azienda Ospedaliera Universitaria G. Martino di Messina, Italy
68 -
CO:07:5 | Enhanced fibroblast signatures in females with early rheumatoid arthritis highlights a potential basis for poorer treatment outcomes Benedetta Monosi1, James Perera2, Alessandra Nerviani2|3, Maria Sole Chimenti1, Felice Rivellese2|3, Costantino Pitzalis2|3|4. | 1Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 2Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; 3Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research, London, UK; 4Department of Biomedical Sciences Humanitas University and IRCCS Humanitas Research Hospital, Milano, Italy
223 -
PO:31:172 | Age and timing of onset of Raynaud's phenomenon and first non-Raynaud sign/symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the systemic sclerosis progression investigation registry of the Italian Society for Rheumatology Silvia Peretti1, Cosimo Bruni2, Silvia Laura Bosello3, Fabio Cacciapaglia4-5, Corrado Campochiaro6-7, Veronica Codullo8, Lorenzo Dagna6-7, Rossella De Angelis9, Giacomo De Luca6-7, Dilia Giuggioli10, Serena Guiducci1, Florenzo Iannone4, Francesca Ingegnoli11, Valeria Riccieri12, Marco Matucci Cerinic6-7, Clodoveo Ferri10-13, Silvia Bellando Randone1. | 1Division of Rheumatology, Scleroderma Unit, Department of Experimental and Clinical Medicine, University of Florence, AO, Firenze, Italy; 2Division of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; 3Rheumatology Division, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli- IRCCS, Roma, Italy; 4Rheumatology Unit, Department of Precision and Regenerative Medicine-Ionian Area, University of Bari Aldo Moro, Bari, Italy; 5Reumatology Service, Internal Medicine Unit F.Miulli General Hospital, Acquaviva delle Fonti -Department of Medicine a, Bari, Italy; 6Unit of Immunology, Rheumatology, Allergy and Rare Diseases UnIRAR, Inflammation, Fibrosis and Ageing initiative INFL, Milano, Italy; 7Vita-Salute San Raffaele University, Milano, Italy; 8Department of Internal Medicine and Therapeutics, Università di Pavia, Italy; Division of Rheumatology, Fondazione IRCCS, Pavia, Italy; 9Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy; 10Rheumatology Unit, School of Medicine, University of Modena and Reggio Emilia, Modena, Italy; 11Division of Clinical Rheumatology, ASST Pini, Dept. of Clinical Sciences and Community Health, Research Center for Adul, Milano, Italy; 12Department of Rheumatology, Sapienza University of Rome, Roma, Italy; 13Rheumatology Clinic Madonna dello Scoglio Crotonei, Crotone, Italy.
266 -
PO:16:231 | Differential clinical features of systemic lupus erythematosus patients on biological therapies: insights from a monocentric cohort Pietro Francesco Pilo, Elisa Bellis, Claudia Garulli, Claudio Cruciani, Marta Saracco, Claudia Lomater, Elena Marucco, Gloria Crepaldi, Valeria Data, Annamaria Iagnocco, Mariele Gatto. | Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.
168 -
PO:24:070 | Preliminary descriptive data from a single-centre cohort of patients with idiopathic inflammatory myopathy: focus on paraneoplastic and non-paraneoplastic patients Silvia Ebe Lucia Della Pina1, Paola Bizioli1, Samantha Mazza2, Caproli Alessia1, Cesare Tomasi1, Ilaria Cavazzana1, Franco Franceschini1. | 1S.C.O. Reumatologia ed Immunologia Clinica, ASST Spedali Civili di Brescia, Università degli Studi di Brescia, Brescia, Italy; 2Università degli Studi di Brescia, Brescia, Italy.
163 -
PO:07:107 | Performance of the 2010 ACR/EULAR classification criteria for Rheumatoid Arthritis in a group of elderly onset patients Alessandra Rai1, Pierluigi Macchioni1, Giovanni Barausse2, Luigi Boiardi1, Giuseppe Paolazzi2, Carlo Salvarani1, Andreina Manfredi1 | 1University of Modena and Reggio Emilia, USL-IRCCS Reggio Emilia, Italy; 2Rheumatology Unit, Ospedale di Trento, Italy
54 -
CO:01:3 | Which PRO reflects remission best? Bridging the gap between patient and physician in systemic lupus erythematosus Elena Ragusa1, Elisabetta Chessa2, Marta Paola Pireddu1, Fabio Congiu1, Giulia Rizzo1, Marianna Salis1, Alessandra Oliva1, Mattia Congia2, Alberto Cauli1|2, Matteo Piga1|2. | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari; 2SC Reumatologia, AOU Cagliari, Italy
286 -
PO:08:116 | Rheumatoid nodulosis: incidence, clinical/instrumental description, and phenotypic correlations in patients with rheumatoid arthritis treated with b-DMARDs. A real-life analysis from a monocentric cohort Stefano Ruggiero1, Elisa Montebelli3, Simone Bernardi2, Marcello Natali4, Francesca Martelli1, Alessandra Caula1, Federica Landolfini1, Gabriella Cucinotta1, Sofia Giulianelli1, Francesco Girelli2 | 1UOC Medicina Interna, Ospedale Morgagni-Pierantoni; Dipartimento di scienze Mediche e Chirurgiche Università di Bologna; 2UOS Reumatologia, Ospedale Morgagni-Pierantoni, Forlì; 3Università degli Studi di Bologna; 4UOC Radiologia, Ospedale Morgagni-Pierantoni, Forlì, Italy
188 -
PO:01:001 | Clinical and histopathological features of refractory psoriatic arthritis undergoing ultrasound-guided synovial biopsy: comparison between non-inflammatory and persistent inflammatory profiles Marianna Tamussin1, Carlo Garaffoni1, Maria Capita1, Serena Ceccato1, Giovanni Lanza2, Mariangela Salvato3, Kiren Khalid3, Francesca Frizzera3, Lorenzo Di Luozzo3, Annalisa Angelini4, Roberta Ramonda3, Alessandra Bortoluzzi1, Andrea Doria3, Marcello Govoni1, Alessadro Giollo3, Ettore Silvagni1 | 1Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna Ferrara, Italy; 2Pathology Unit, Department of Translational Medicine, University of Ferrara, Ferrara Ferrara, Italy; 3Rheumatology Unit, Department of Medicine , DIMED, University of Padua Padova, Italy; 4Cardiovascular Pathology, Department of Cardiac, Thoracic, Vascular Sciences and Pulic Health, University of Padua, Padova, Italy
39 -
PO:06:083 | Clinical characteristics and outcomes of late- and young-onset rheumatoid arthritis in relation to autoantibody status Federica Sabatelli1|2, Ludovico De Stefano1|2, Clelia Zampaglione1|2, Lisa Bergianti1|2, Blerina Xoxi1|2, Antonio Manzo1|2, Carlomaurizio Montecucco1|2, Serena Bugatti1|2. | 1Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; 2Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
154 -
CO:07:6 | Hidden in plain sight: fibromyalgia prevalence and correlates in 3,000 non-clinical Italian subjects Sergio Del Vescovo1, Vincenzo Venerito1, Maria Giannotta1, Maria Grazia Anelli1, Maria Morrone1, Angelo Troiano1, Marco Capodiferro1, Marco Fornaro1, Giuseppe Lopalco1, Florenzo Iannone1. | 1UOC Reumatologia, DiMePre-J, Policlinico di Bari, Italy
209 -
PO:04:046 | Achieving Early Clinical Response was Associated with Cumulative Benefits on Disease Impact up to 2 Years in Patients with Active Psoriatic Arthritis Treated with Bimekizumab William Tillett1|2, Joseph F Merola3, Iain B Mcinnes4, Kenneth B Gordon5, Richard B Warren6, Patrick Healy7, Jérémy Lambert8, Heather Edens9, Barbara Ink10, Paola Volpe11, Laure Gossec12 | 1Royal National Hospital of Rheumatic Diseases Bath, United Kingdom; 2Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath Bath, United Kingdom; 3Department of Dermatology and Department of Medicine, Division of Rheumatology, Utah Southwestern Medical Center Dallas, USA; 4College of Medical Veterinary and Life Sciences, University of Glasgow Glasgow, United Kingdom; 5Department of Dermatology, Medical College of Wisconsin Milwaukee, USA; 6Northern Care Alliance, NHS Foundation Trust and Manchester Academic Health Science Centre, University of Manchester Manchester, United Kingdom; 7UCB Morrisville, USA; 8UCB Colombes, France; 9UCB Smyrna, USA; 10UCB Slough, United Kingdom; 11UOC Reumatologia, P.O. Spirito Santo Pescara, Italy; 12Sorbonne Universite and Pitie-Salpetriere Hospital Paris, France
59 -
PO:34:209 | Increased liver stiffness and fibrosis in systemic sclerosis: a single-center transient elastography cohort study. Nicola Ortalli1|2, Simone Aldo Lari1|2, Alessandra Vacca3, Erika Meleddu1|2, Alberto Civolani4, Emanuela Vargiu4, Alberto Floris1|2, Massimo Claudio Fantini4, Alberto Cauli1|2. | 1Rheumatology Unit, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy; 2Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; 3Rheumatology Unit, Presidio Ospedaliero CTO di Iglesias Iglesias Italy; 4Gastroenterology Unit, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy.
184 -
PO:02:022 | Bimekizumab Maintained Stringent Clinical Responses over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies Fabian Proft1, Désirée Van Der Heijde2, Sergio Schwartzman3|4|5, Joerg Ermann6, Alexander Marten7, Ute Massow7, George Stojan8, Vanessa Taieb9, Diana Voiniciuc10, Astrid Van Tubergen11, Victoria Navarro-Compán12, Simone Angioni13, Xenofon Baraliakos14 | 1Charité-Universitätsmedizin Berlin; Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; 2Department of Rheumatology, Leiden University Medical Center Leiden, The Netherlands; 3Weill Cornell Medical Center New York, USA; 4New York Presbyterian Hospital New York, USA; 5Hospital for Special Surgery New York, USA; 6Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School Boston, USA; 7UCB Monheim am Rhein Germany; 8UCB Atlanta, USA; 9UCB Colombes, France; 10UCB Slough, United Kingdom; 11Department of Medicine, Division of Rheumatology, Maastricht University Medical Center Maastricht, The Netherlands; 12Department of Rheumatology, La Paz University Hospital, IdiPaz Madrid, Spain; 13UCB Milan, Italy; 14Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Germany
41 -
CO:09:3 | Effectiveness and safety of nintedanib in autoimmune systemic diseases: real life data from an Italian multicentre study (Island group) of the Italian Society of Rheumatology Corrado Campochiaro1, Paola Conigliaro2, Gianluca Sambataro3, Marco Matucci-Cerinic1, Marco Sebastiani4, Gianluca Bajocchi5, Angelo Fassio6, Elena Treppo7, Elisabetta Zanatta8, Elena Bartolini9, Francesco Ferro10, Chiara Bazzini11, Nicoletta Del Papa12, Gemma Lepri13, Andrea Lo Monaco14, Marta Favero15, Annamaria Iuliano16, Francesca Li Gobbi17, Maria Sole Chimenti2, Giuseppe Muscato18, Giacomo De Luca1, Francesca Cozzini4, Lucia Dardani5, Francesco Pollastri6, Alessandro Gattron7, Beatrice Moccaldi8, Caterina Antonini9, Gaetano La Rocca10, Ilaria Cavazzana11, Andreina Manfredi5|19. | 1IRCCS San Raffaele Hospital, Vita-Salute San Raffaele, Milano; 2U.O.C. Reumatologia Dipartimento di Medicina dei Sistemi Università di Roma-Tor Vergata, Roma; 3Università Kore, Enna; 4University of Parma, Azienda Ospedaliera di Piacenza; 5UOC Reumatologia, AUSL IRCCS Reggio Emilia; 6UOC Reumatologia Università degli Studi di Verona; 7Dipartimento di Medicina, Clinica di Reumatologia, Università degli Studi di Udine; 8UOC Reumatologia, Dipartimento di Medicina DIMED, Azienda Ospedale Università di Padova; 9SC Interaziendale di Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia, Azienda Integrata Università; 10Dipartimento di Medicina Clinica e Sperimentale UO Reumatologia-Universitaria AOU Pisa; 11U.O. Reumatologia e Immunologia Clinica ASST Spedali Civili di Brescia; 12Clinica Reumatologica, Milano; 13S.O.D. di Reumatologia AOU Careggi, Firenze; 14UOC Reumatologia Azienda Ospedaliero-Universitaria Sant'Anna, Ferrara; 15Internal Medicine I, Department of Medicine, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Treviso; 16UOC Reumatologia, AO San Camillo Forlanini, Roma; 17Rheumatology Unit, S.Giovanni di Dio Hospital, Firenze; 18Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Disease, Policlinico, Catania; 19Università degli Studi di Modena e Reggio Emilia, Italy
183 -
PO:26:097 | Ultrasound evaluation of temporomandibular disorders: comparative analysis between inflammatory and degenerative patterns in patients with and without rheumatological pathologies Beatrice Maranini1, Stefano Mandrioli2, Fabio Fabbian3, Tommaso Bianchi1, Manlio Galiè2, Marcello Govoni1 | 1UO di Reumatologia, Dipartimento di Scienze Mediche, Università di Ferrara; 2UO di Chirurgia Maxillo-Facciale, Dipartimento Testa-Collo, Università di Ferrara; 3Dipartimento di Scienze Mediche, Università di Ferrara, Italy
197 -
PO:24:058 | Serum ferritin as a biomarker in idiopathic inflammatory myopathies with interstitial lung disease: baseline levels and longitudinal trends Silvia Grazzini1, Edoardo Conticini1, Marco Fornaro2, Chiara Rizzo3, Federica Camarda3, Paolo Cameli4, Miriana D'Alessandro4, Lidia La Barbera3, Stefano Stano2, Maria Rosa Pellico5, Latika Gupta6, Florenzo Iannone2, Giuliana Guggino3, Elena Bargagli4, Nicoletta Del Papa5, Luca Cantarini1, Bruno Frediani1. | 1Reumatologia, Dipartimento di Scienze Mediche, Chirugiche e Neuroscienze, Università di Siena, Siena, Italy; 2Reumatologia, Dipartimento di Emergenza e Trapianto d'Organo, Università di Bari, Bari, Italy; 3Reumatologia, Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica, Università di Palermo, Palermo, Italy; 4Pneumologia, Dipartimento di Scienze Mediche, Chirugiche e Neuroscienze, Università di Siena, Siena, Italy; 5Reumatologia Clinica e Scienze Mediche, ASST Gaetano Pini CTO, Milano, Italy; 6University of Manchester, Manchester, United Kingdom.
188 -
PO:12:186 | Clinical, functional, and microvascular features in the early diagnosis and management of pulmonary hypertension in systemic sclerosis: the importance of multimodal screening strategies Irene Carlino1, Stefania Bisogno1, Alberto Palazzuoli2, Luigi Gennari1 | 1U.O.C. Reumatologia, Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Università di Siena, A.O.U. Senese; 2Azienda Sanitaria Locale, Novara, Italy
188 -
PO:23:046 | Histopathological comparison between minor salivary gland biopsies from pediatric and adult patients with Sjögren’s disease: evidence of a more severe inflammatory profile in early-onset cases Flavia Riccio1, Mattia Neri2, Martina Mellone1, Immacolata Cozzolino3, Jacopo Ferro4, Valerio Gaetano Vellone4, Ciro Emiliano Boschetti5, Giuseppe Colella5, Nicola Laffi6, Pietro Buono7, Enrico Tirri8, Renato Franco3, Marco Gattorno2, Francesco Ciccia1, Clara Malattia2, Saviana Gandolfo8 | 1UOC di Reumatologia, Università degli Studi della Campania Luigi Vanvitelli, Napoli; 2UOC di Reumatologia e Malattie Autoinfiammatorie, Istituto Giannina Gaslini, Genova; 3UO di Anatomia Patologica, Università degli Studi della Campania Luigi Vanvitelli, Napoli; 4UOC di Anatomia Patologica, Istituto Giannina Gaslini Genova; 5UOC di Chirurgia Maxillo-facciale, Università degli Studi della Campania Luigi Vanvitelli, Napoli; 6UO di Odontoiatria, Istituto Giannina Gaslini, Genova; 7UOD Attività consultoriali e assistenza materno-infantile, Direttorato Generale per la Salute, Regione Campania, Napoli; 8UO di Reumatologia, Ospedale del Mare, Napoli, Italy
193 -
PO:03:044 | Impact of Inflammatory Bowel Disease on Clinical Phenotype and Treatment Response in Patients with Psoriatic Arthritis Maria Morrone1, Maria Giannotta1, Vincenzo Venerito1, Greta Giulia Dipietrangelo1, Stefano Stano1, Florenzo Iannone1, Giuseppe Lopalco1 | 1Department of Precision and Regenerative Medicine and Ionian Area DiMePRe-J University of Bari, Bari, Italy
42
